African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women. uri icon

Overview

publication date

  • June 29, 2009

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Black or African American
  • Breast Neoplasms
  • Receptors, Estrogen
  • White People

Identity

PubMed Central ID

  • PMC4813786

Scopus Document Identifier

  • 68949094309

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.21.5509

PubMed ID

  • 19564528

Additional Document Info

volume

  • 27

issue

  • 22